The Roche Investor Relations team would like to invite you to the Roche Pharma Day that will take place in London on Monday, 22 September 2025, starting at 09:00 BST and will finish at 14:30 BST with a reception. The Roche Pharma Day will address the following topics: Pharma strategy and commercial growth drivers R&D Excellence Pipeline updates Oncology / Hematology, Neurology, Ophthalmology, Immunology, CVRM Presenters will include: Teresa Graham, CEO Roche Pharmaceuticals Levi Garraway, CMO and Global Head of Product Development Charles Fuchs, SVP and Global Head of Oncology and Hematology Product Development Hideki Garren, SVP and Global Head of Neurology Product Development Larry Tsai, SVP and Global Head of Immunology Product Development Christopher Brittain, SVP and Global Head of Ophthalmology Product Development Manu Chakravarthy, SVP and Global Head of CVRM Product Development You will have the opportunity to meet senior management during the event.   Meeting information:  Date/Time (BST): Monday, 22 September 2025 09:00 Registration 09:30 Event starts 14:30 Event ends, followed by refreshments with the Roche Management Team Venue Pan Pacific London  80 Houndsditch London EC3A 7AB > map To register for the event, please follow this > link (passcode: Pharma2025) The slides will be available for download at 8:30 BST on the day of the event. > click here   Alternatively you may participate virtually in the webinar (no access to speakers, pre-registration required). Please pre-register for the webinar here*.   Should you be unable to register for the webinar due to your company IT policy, please send an e-mail to investor.relations@roche.com .   A replay of the event will be available via > ir.roche.com *privacy notice   Best regards,
Bruno Eschli Head of Investor Relations
Roche Investor Relations
Dr. Bruno Eschli Phone: +41 61 68-75284 e-mail: bruno.eschli@roche.com	Dr. Sabine Borngräber Phone: +41 61 68-88027 e-mail: sabine.borngraeber@roche.com
Dr. Birgit Masjost Phone: +41 61 68-84814 e-mail: birgit.masjost@roche.com
Investor Relations North America
Loren Kalm Phone: +1 650 225 3217 e-mail: kalm.loren@gene.com

get the latest news and updates to your inbox.